Chlorodehydromethyltestosterone, commonly called Oral Turinabol, is a synthetic derivative within the anabolic-androgenic steroid family. It was developed from structural modifications of related steroid compounds.

Its oral formulation incorporates a 17-alpha-alkyl group, allowing activity following oral administration while making hepatic effects an important consideration. The compound has both anabolic and androgenic properties.

Potential consequences of exposure include suppression of endogenous testosterone production, altered lipid profiles, liver abnormalities, and reproductive effects. A specific pharmaceutical status should not be inferred solely from the word “pharmacy” in a product name.